3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Glioma
1
Gastrointestinal Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Basal Cell
1
Interventions
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Oxaliplatin
2
Leucovorin
2
Cholecalciferol
2
Cetuximab
2
sodium thiosulfate
1
nilotinib
1
gallium 68 PSMA-11
1
epigallocatechin gallate
1
delta-8-tetrahydrocannabinol
1
clevudine
1
X-Rays
1
Vaccines
1
Tea
1
Specimen Handling
1
Reverse Transcriptase Polymerase Chain Reaction
1
Receptor Protein-Tyrosine Kinases
1
Radiotherapy
1
Platinum
1
Pentoxifylline
1
Panitumumab
1
Microscopy, Electron
1
Metastasectomy
1
Irinotecan
1
Hyperthermic Intraperitoneal Chemotherapy
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Folfox protocol
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Colonic Neoplasms
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled